182 related articles for article (PubMed ID: 16083813)
21. Hypersensitivity to mosquito bites in association with chronic Epstein-Barr virus infection and natural killer (NK) leukaemia/lymphoma with expansion of NK cells expressing a low level of CD56.
Adachi A; Horikawa T; Kunisada M; Hayashi K; Ohshima K; Matsuoka H; Tokura Y
Br J Dermatol; 2002 Nov; 147(5):1036-7. PubMed ID: 12410732
[No Abstract] [Full Text] [Related]
22. A case of exaggerated mosquito-bite hypersensitivity with Epstein-Barr virus-positive inflammatory cells in the bite lesion.
Ohsawa T; Morimura T; Hagari Y; Kawakami T; Mihara M; Hirai K; Ikuta K; Murakami M; Sairenji T; Matsuse T
Acta Derm Venereol; 2001; 81(5):360-3. PubMed ID: 11800146
[TBL] [Abstract][Full Text] [Related]
23. Vidarabine therapy for severe chronic active Epstein-Barr virus infection.
Kimura H; Morita M; Tsuge I; Hoshino Y; Tanaka N; Ito Y; Morishima T
J Pediatr Hematol Oncol; 2001; 23(5):294-9. PubMed ID: 11464986
[TBL] [Abstract][Full Text] [Related]
24. Primary EBV infection and hypersensitivity to mosquito bites: a case report.
Kyriakidis I; Vasileiou E; Karastrati S; Tragiannidis A; Gompakis N; Hatzistilianou M
Virol Sin; 2016 Dec; 31(6):517-520. PubMed ID: 27900557
[TBL] [Abstract][Full Text] [Related]
25. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease.
Kawa K; Okamura T; Yagi K; Takeuchi M; Nakayama M; Inoue M
Blood; 2001 Nov; 98(10):3173-4. PubMed ID: 11721684
[No Abstract] [Full Text] [Related]
26. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
27. Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.
Yamada M; Ishikawa Y; Imadome KI
Allergol Int; 2021 Oct; 70(4):430-438. PubMed ID: 34334322
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma following mosquito bites in an elderly patient without prior hypersensitivity.
Tomita N; Kanamori H; Fujimaki K; Fujisawa S; Ishigatsubo Y
Leuk Lymphoma; 2004 Oct; 45(10):2153-5. PubMed ID: 15370264
[TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in Korea.
Chung JS; Shin HJ; Lee EY; Cho GJ
Korean J Intern Med; 2003 Mar; 18(1):50-2. PubMed ID: 12760269
[TBL] [Abstract][Full Text] [Related]
30. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T
Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311
[TBL] [Abstract][Full Text] [Related]
31. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Kawa K
Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
[No Abstract] [Full Text] [Related]
32. [EB virus and skin diseases].
Asada H
Gan To Kagaku Ryoho; 2013 Apr; 40(4):462-5. PubMed ID: 23894755
[No Abstract] [Full Text] [Related]
33. A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB).
Ohshima S; Ishii M; Asada H; Tatekawa T; Yamaguchi N; Kobayashi H; Ishii T; Mima T; Kawase I; Saeki Y
Intern Med; 2002 Aug; 41(8):651-6. PubMed ID: 12211536
[TBL] [Abstract][Full Text] [Related]
34. [A case of the development of chronic glomerulonephritis following mosquito bites].
Ryss ES; Rumiantsev ASh; Kisina AA; Akimova SL; Nabokov AV; Rakitianskaia IA; Travkina ES
Ter Arkh; 1991; 63(6):132-4. PubMed ID: 1683019
[No Abstract] [Full Text] [Related]
35. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells.
Ishihara S; Ohshima K; Tokura Y; Yabuta R; Imaishi H; Wakiguchi H; Kurashige T; Kishimoto H; Katayama I; Okada S; Kawa-Ha K
Jpn J Cancer Res; 1997 Jan; 88(1):82-7. PubMed ID: 9045900
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
37. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
38. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
39. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
40. Extranodal type T/NK-cell lymphoma with an atypical clinical presentation.
Aydin GB; Akyuz C; Talim B; Evans SE; Sahin S; Sari N; Tabanlioglu D; Ozen S; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Jun; 24(4):291-9. PubMed ID: 17613872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
